Literature DB >> 21535915

Age-dependent availability and functionality of bone marrow stem cells in an experimental model of acute and chronic myocardial infarction.

Ana Ayala-Lugo1, Angela M V Tavares, Ana H R Paz, Ana Alegretti, Ludmila Miquelito, Hugo Bock, Roberto Giugliani, Nadine Clausell, Elizabeth Cirne-Lima, Luis E Rohde.   

Abstract

The aim of this study was to investigate the effect of aging and timing of left ventricular ischemic injury on the availability and functionality of stem cells. We studied young and aged male inbred Lewis rats that were used as donors of bone marrow mononuclear cells (BM-MNCs), divided in four experimental groups: controls, sham operated, 48 h post-myocardial infarction (MI), and 28 days post-MI. In vitro studies included flow cytometry analysis, hematopoietic colony-forming capacity, and invasion assays of migration capacity. BM-MNCs from these groups were transplanted in female rats after MI induction. Late engraftment was evaluated by real-time PCR of the SRY chromosome. Percentage of CD34+/CD45+(low) cells was similar among different experimental groups in young rats, but was significantly higher in aged animals (p < 0.001), particularly 28 days post-MI. KDR+/CD34+ cells were increased 48 h after MI and decreased 28 days post-MI in young animals, while they were profoundly reduced in the aged group (p < 0.001). Triple staining for CD44+/CD29+/CD71+ cells was similar in different groups of aged rats, but we observed an intense increase 48 h post-MI in young animals. Colony-forming units and cytokine-induced migration were significantly attenuated 28 days after the MI. Late engraftment in infarcted transplanted female hearts was present, but considerably heterogeneous. Finally, recovery of left ventricular systolic function in transplanted female recipients was significantly influenced by donors' BM-MNCs groups (p < 0.01). We have demonstrated that aging and timing of myocardial injury are factors that may act synergistically in determining stem cell availability and function. Such interaction should be considered when planning new cell therapy strategies for acute and chronic ischemic heart disease in the clinical arena.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21535915     DOI: 10.3727/096368909X519283

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  7 in total

Review 1.  Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.

Authors:  Ronak Delewi; Alexander Hirsch; Jan G Tijssen; Volker Schächinger; Wojciech Wojakowski; Jérôme Roncalli; Svend Aakhus; Sandra Erbs; Birgit Assmus; Michal Tendera; R Goekmen Turan; Roberto Corti; Tim Henry; Patricia Lemarchand; Ketil Lunde; Feng Cao; Heikki V Huikuri; Daniel Sürder; Robert D Simari; Stefan Janssens; Kai C Wollert; Michal Plewka; Stefan Grajek; Jay H Traverse; Felix Zijlstra; Jan J Piek
Journal:  Eur Heart J       Date:  2013-09-11       Impact factor: 29.983

Review 2.  Epigenetic mechanisms underlying cardiac degeneration and regeneration.

Authors:  Pankaj Chaturvedi; Suresh C Tyagi
Journal:  Int J Cardiol       Date:  2014-02-20       Impact factor: 4.164

3.  Age-Related Impaired Efficacy of Bone Marrow Cell Therapy for Myocardial Infarction Reflects a Decrease in B Lymphocytes.

Authors:  Songtao An; Xiaoyin Wang; Melissa A Ruck; Hilda J Rodriguez; Dmitry S Kostyushev; Monika Varga; Emmy Luu; Ronak Derakhshandeh; Sergey V Suchkov; Scott C Kogan; Michelle L Hermiston; Matthew L Springer
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

Review 4.  Extracellular vesicles and cardiovascular disease therapy.

Authors:  Jérémy Amosse; Maria Carmen Martinez; Soazig Le Lay
Journal:  Stem Cell Investig       Date:  2017-12-30

5.  Advanced Donor Age Impairs Bone Marrow Cell Therapeutic Efficacy for Cardiac Disease.

Authors:  Xiaoyin Wang; Junya Takagawa; Daniel J Haddad; Kranthi Pinnamaneni; Yan Zhang; Richard E Sievers; William Grossman; Yerem Yeghiazarians; Matthew L Springer
Journal:  J Tissue Sci Eng       Date:  2011-11-18

6.  Aging increases the susceptivity of MSCs to reactive oxygen species and impairs their therapeutic potency for myocardial infarction.

Authors:  Liang Li; Yingfei Guo; Hongxia Zhai; Yaxin Yin; Jinjin Zhang; Haiwei Chen; Lei Wang; Na Li; Runmei Liu; Yunfeng Xia
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

Review 7.  The Evolution of the Stem Cell Theory for Heart Failure.

Authors:  Jean-Sébastien Silvestre; Philippe Menasché
Journal:  EBioMedicine       Date:  2015-11-05       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.